These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12374252)

  • 1. Statin lipid-lowering therapy for acute myocardial infarction and unstable angina: efficacy and mechanism of benefit.
    Wright RS; Murphy JG; Bybee KA; Kopecky SL; LaBlanche JM
    Mayo Clin Proc; 2002 Oct; 77(10):1085-92. PubMed ID: 12374252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).
    Murphy SA; Cannon CP; Wiviott SD; de Lemos JA; Blazing MA; McCabe CH; Califf RM; Braunwald E
    Am J Cardiol; 2007 Oct; 100(7):1047-51. PubMed ID: 17884359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial.
    Ray KK; Cannon CP; McCabe CH; Cairns R; Tonkin AM; Sacks FM; Jackson G; Braunwald E;
    J Am Coll Cardiol; 2005 Oct; 46(8):1405-10. PubMed ID: 16226162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term benefit of statin therapy initiated during hospitalization for an acute coronary syndrome: a systematic review of randomized trials.
    Bavry AA; Mood GR; Kumbhani DJ; Borek PP; Askari AT; Bhatt DL
    Am J Cardiovasc Drugs; 2007; 7(2):135-41. PubMed ID: 17503884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins in acute coronary syndromes: do the guideline recommendations match the evidence?
    Morrissey RP; Diamond GA; Kaul S
    J Am Coll Cardiol; 2009 Oct; 54(15):1425-33. PubMed ID: 19796735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early statin initiation and outcomes in patients with acute coronary syndromes.
    Newby LK; Kristinsson A; Bhapkar MV; Aylward PE; Dimas AP; Klein WW; McGuire DK; Moliterno DJ; Verheugt FW; Weaver WD; Califf RM;
    JAMA; 2002 Jun; 287(23):3087-95. PubMed ID: 12069671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The case for intensive statin therapy after acute coronary syndromes.
    Schwartz GG; Olsson AG
    Am J Cardiol; 2005 Sep; 96(5A):45F-53F. PubMed ID: 16126023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early time to benefit with intensive statin treatment: could it be the pleiotropic effects?
    Ray KK; Cannon CP
    Am J Cardiol; 2005 Sep; 96(5A):54F-60F. PubMed ID: 16126024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial.
    Rouleau J
    Am J Med; 2005 Dec; 118 Suppl 12A():28-35. PubMed ID: 16356805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early statin treatment in acute coronary syndrome. Is this evidence-based?].
    Jensen LO; Hansen HS
    Ugeskr Laeger; 2002 Jul; 164(27):3519-22. PubMed ID: 12116678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical focus on statins.
    Auer J; Eber B
    Curr Opin Investig Drugs; 2001 Mar; 2(3):382-8. PubMed ID: 11575709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early statin therapy in acute coronary syndromes: the successful cycle of evidence, guidelines, and implementation.
    Waters DD; Ku I
    J Am Coll Cardiol; 2009 Oct; 54(15):1434-7. PubMed ID: 19796736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22).
    Ray KK; Morrow DA; Shui A; Rifai N; Cannon CP
    Am J Cardiol; 2006 Oct; 98(7):861-5. PubMed ID: 16996863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial.
    Murphy SA; Cannon CP; Wiviott SD; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2009 Dec; 54(25):2358-62. PubMed ID: 20082923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators.
    Marschner IC; Colquhoun D; Simes RJ; Glasziou P; Harris P; Singh BB; Friedlander D; White H; Thompson P; Tonkin A;
    J Am Coll Cardiol; 2001 Jul; 38(1):56-63. PubMed ID: 11451296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial.
    Thompson PL; Meredith I; Amerena J; Campbell TJ; Sloman JG; Harris PJ;
    Am Heart J; 2004 Jul; 148(1):e2. PubMed ID: 15215811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.
    Chan PS; Nallamothu BK; Gurm HS; Hayward RA; Vijan S
    Circulation; 2007 May; 115(18):2398-409. PubMed ID: 17452609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
    Ray KK; Cannon CP; Ganz P
    Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes.
    Lenderink T; Boersma E; Gitt AK; Zeymer U; Wallentin L; Van de Werf F; Hasdai D; Behar S; Simoons ML
    Eur Heart J; 2006 Aug; 27(15):1799-804. PubMed ID: 16820364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.